Projected Out-of-Pocket Savings of the Medicare Part D $2 Drug List Model
This study evaluates the amount of out-of-pocket cost savings Medicare Part D beneficiaries would have experienced if a proposed Medicare $2 drug list model had been in place in 2021.
Authors
- Inmaculada Hernandez (ORCID: https://orcid.org/0000-0002-0118-4986)
- Nico Gabriel (ORCID: https://orcid.org/0000-0003-1793-2245)
- Yashwant Pathak (ORCID: https://orcid.org/0000-0002-5251-4308)
- Ryan N. Hansen (ORCID: https://orcid.org/0000-0003-3887-1242)
- A. Mark Fendrick (ORCID: https://orcid.org/0000-0002-7734-6742)
- Sean D. Sullivan
Institutions
- University of Washington (US)
- University of Michigan (US)
- West Health (US)
- University of California San Diego (US)
- University of Montana (US)
Publication Details
- Journal
- JAMA
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1001/jama.2025.2028
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00